SCTX insider buying
Every open-market purchase of Scribe Therapeutics, Inc. (SCTX) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$71.34M
Insiders buying (12m)6
Purchases on record6
Last purchase filedJul 29, 2026
In the last 12 months, 6 insiders of Scribe Therapeutics, Inc. bought $71.34M of SCTX stock on the open market in 6 reported purchases. The most recent was filed on Jul 29, 2026: AH Equity Partners Bio II, L.L.C. +5 (10% Owner) bought 333,333 shares at $15.00, worth $5M. The largest purchase on record here is $36.26M by Avoro Ventures LLC +2 on Jul 24, 2026.
Get the next SCTX insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll SCTX insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Jul 29 | AH Equity Partners Bio II, L…10% Owner | $5M | 333,333 | $15.00 | +16% | Jul 27 | SEC |
| Jul 29 | Gordon Carl LDirector | $15M | 1,000,000 | $15.00 | +287% | Jul 27 | SEC |
| Jul 29 | Orbimed Advisors LLC +1Director | $15M | 1,000,000 | $15.00 | +287% | Jul 27 | SEC |
| Jul 28 | Avoro Ventures LLC +2Director | $36.26M | 2,391,238 | $15.16 | +374% | Jul 24 | SEC |
| Jul 27 | Parrot DavidChief Financial Officer | $39.99K | 2,666 | $15.00 | new | Jul 23 | SEC |
| Jul 27 | Lucas SvetlanaChief Business Officer | $45K | 3,000 | $15.00 | new | Jul 23 | SEC |